The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Cerebral ischemia and neuroregeneration
Open accessAbstract
Cerebral ischemia is one of the leading causes of morbidity and mortality worldwide. Although stroke (a form of cerebral ischemia)-related costs are expected to reach 240.67 billion dollars by 2030, options for treatment against cerebral ischemia/stroke are limited. All therapies except anti-thrombolytics (i.e., tissue plasminogen activator) and hypothermia have failed to reduce neuronal injury, neurological deficits, and mortality rates following cerebral ischemia, which suggests that development of novel therapies against stroke/cerebral ischemia are urgently needed. Here, we discuss the possible mechanism(s) underlying cerebral ischemia-induced brain injury, as well as current and future novel therapies (i.e., growth factors, nicotinamide adenine dinucleotide, melatonin, resveratrol, protein kinase C isozymes, pifithrin, hypothermia, fatty acids, sympathoplegic drugs, and stem cells) as it relates to cerebral ischemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029 · cited 1×
“Oxyradicals, NO, and peroxynitrite play a crucial role in the pathological progression of neuronal cell death following cerebral ischemia (Beckman et al., 1990; Crow and Beckman, 1995), which suggests that melatonin may provide neuroprotection against cerebral ischemia.”
BackgroundThrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Dávalos, A., Guidetti, D., Larrue, V., Lees, K. R., Medeghri, Z., Machnig, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804656 · Cited by 6,684 · cited 2×
“, 2017) is the only FDA approved therapy for the treatment of acute ischemic stroke (Hacke et al., 2008; Zivin, 2009; Farbu et al., 2011; Cheng and Kim, 2015).”
BackgroundLopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68770-9 · Cited by 5,630 · cited 14×
“Subsequent studies by Leker et al, 2007 and Yoshimura et al, 2001 further indicate that up-regulation of FGF-2 via adeno-associated viral vectors in the infarct area can increase the number of proliferating cells and motor behavior after MCAO (Yoshimura et al., 2001; Leker et al., 2007).”
BackgroundInfluentialGage, F. H. (2000) · Science · doi:10.1126/science.287.5457.1433 · Cited by 4,786
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio711 · Cited by 3,068 · cited 1×
“…cellular excitotoxicity, cerebral ischemia alone can induce overexpression of the death receptor ligands (i.e., tumor necrosis factor (TNF)-α and FasL), as a result of serine/threonine-protein kinase 1-mediated neuronal necroptosis (Holler et al., 2000; Degterev et al., 2005, 2008).”
BackgroundSterile inflammation: sensing and reacting to damage
Chen, G. Y., & Nuñez, G. (2010) · Nature Reviews Immunology · doi:10.1038/nri2873 · Cited by 3,051 · cited 3×
“…death to initiate series of innate immune responses, as a result of excessive production of proin- flammatory cytokines/chemokines (Iyer et al., 2009; Chen and Nunez, 2010; McDonald et al., 2010), which causes peroxynitrite- and ROS-mediated lipid peroxidation, DNA damage, and cell…”
BackgroundFeigin, V. L., Lawes, C. M., Bennett, D. A., Barker-Collo, S. L., & Parag, V. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70025-0 · Cited by 2,855 · cited 2×
“Despite improved education (i.e., dietary), psychological care, and better therapeutic treatments [i.e., less door-toneedle time for plasminogen activator], cerebral ischemia is still one of the leading causes of morbidity and mortality worldwide (Lopez et al., 2006; Feigin et al., 2009).”
BackgroundNeuronal replacement from endogenous precursors in the adult brain after stroke
Arvidsson, A., Collin, T., Kirik, D., Kokaia, Z., & Lindvall, O. (2002) · Nature Medicine · doi:10.1038/nm747 · Cited by 2,799 · cited 1×
“Mechanisms underlying endogenous stem cell therapies against cerebral ischemia are highly complicated and remains to be elucidated (Arvidsson et al., 2002).”
BackgroundSystemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144 · cited 1×
“…free radicals (i.e., ROS), reactive nitrogen species, cyclooxygenase-2, and inducible nitric oxide synthase] to cause secondary neuronal cell death (Qin et al., 2007; Erickson and Banks, 2011; Tremblay et al., 2011; Park et al., 2012; Biesmans et al., 2013; Hernandez-Ontiveros et al., 2013; Kabadi…”
BackgroundIdentification of RIP1 kinase as a specific cellular target of necrostatins
Degterev, A., Hitomi, J., Germscheid, M., Ch'en, I. L., Korkina, O., Teng, X., Abbott, D., Cuny, G. D., Yuan, C., Wagner, G., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.83 · Cited by 2,059 · cited 1×
“…cellular excitotoxicity, cerebral ischemia alone can induce overexpression of the death receptor ligands (i.e., tumor necrosis factor (TNF)-α and FasL), as a result of serine/threonine-protein kinase 1-mediated neuronal necroptosis (Holler et al., 2000; Degterev et al., 2005, 2008).”
BackgroundMechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
Wardlaw, J. M., Smith, C., & Dichgans, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70060-7 · Cited by 1,657
Intracerebral haemorrhage: mechanisms of injury and therapeutic targets
Keep, R. F., Hua, Y., & Xi, G. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70104-7 · Cited by 1,308
Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation
McDonald, B., Pittman, K., Menezes, G. B., Hirota, S. A., Slaba, I., Waterhouse, C. C. M., Beck, P. L., Muruve, D. A., & Kubes, P. (2010) · Science · doi:10.1126/science.1195491 · Cited by 1,210
Excitotoxicity and stroke: Identifying novel targets for neuroprotection
Lai, T. W., Zhang, S., & Wang, Y. T. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.11.006 · Cited by 1,106
The Role of Microglia in the Healthy Brain: Figure 1.
Tremblay, M.-È., Stevens, B., Sierra, A., Wake, H., Bessis, A., & Nimmerjahn, A. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4158-11.2011 · Cited by 992 · cited 1×
“…ROS), reactive nitrogen species, cyclooxygenase-2, and inducible nitric oxide synthase] to cause secondary neuronal cell death (Qin et al., 2007; Erickson and Banks, 2011; Tremblay et al., 2011; Park et al., 2012; Biesmans et al., 2013; Hernandez-Ontiveros et al., 2013; Kabadi and Faden, 2014).”
BackgroundReducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke
Clarkson, A. N., Huang, B. S., MacIsaac, S. E., Mody, I., & Carmichael, S. T. (2010) · Nature · doi:10.1038/nature09511 · Cited by 869 · cited 2×
“Transplantation of NPCs following ischemic stroke results in the migration of mature and immature neurons towards the injured brain regions, as a result of long-term cell survival, electrical balance, synaptic plasticity recovery (Daadi et al., 2009; Clarkson et al., 2010; Darsalia et al., 2011; Bacigaluppi et al., 20…”
BackgroundNeuroinflammation after traumatic brain injury: Opportunities for therapeutic intervention
Kumar, A., & Loane, D. J. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.008 · Cited by 710
The bright side of the glial scar in CNS repair
Rolls, A., Shechter, R., & Schwartz, M. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2591 · Cited by 674 · cited 4×
“…is formed by reactive astrocytes, microglia, and infiltrating immune cells to protect survival neurons from the harmful environment (i.e., nitric oxide toxicity and glutamate-induced cellular excitotoxicity) (Reier and Houle, 1988; Fitch and Silver, 1997; Rolls et al., 2009; Huang et al., 2014b).”
BackgroundInfluentialA peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia
Borsello, T., Clarke, P. G. H., Hirt, L., Vercelli, A., Repici, M., Schorderet, D. F., Bogousslavsky, J., & Bonny, C. (2003) · Nature Medicine · doi:10.1038/nm911 · Cited by 658
Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity
Xanthos, D. N., & Sandkühler, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3617 · Cited by 580
The role of the nitric oxide pathway in brain injury and its treatment — From bench to bedside
Garry, P. S., Ezra, M., Rowland, M. J., Westbrook, J., & Pattinson, K. T. S. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2014.10.017 · Cited by 380 · cited 2×
“damage, and cell dysfunction/death (Garry et al., 2015).”
BackgroundIschemia-Reperfusion Injury in Stroke
Nour, M., Scalzo, F., & Liebeskind, D. S. (2012) · Interventional Neurology · doi:10.1159/000353125 · Cited by 316 · cited 2×
“#These authors contributed equally to this work. orcid: 0000-0003-1010-5423 (Hung Wen Lin) doi: 10.4103/1673-5374.228711 Accepted: 2018-02-01 able CA1 region of the hippocampus and cortex (Kirino, 1982; White et al., 1996; Schaller and Graf, 2004; Nour et al., 2013).”
BackgroundInfluentialKobayashi, T., Ahlenius, H., Thored, P., Kobayashi, R., Kokaia, Z., & Lindvall, O. (2006) · Stroke · doi:10.1161/01.str.0000236025.44089.e1 · Cited by 201 · cited 1×
“…factor, glial cell-derived neurotrophic factor, FGF-2, insulin-like growth factor-1, and brain-derived neurotrophic factor (Dempsey et al., 2003; Kobayashi et al., 2006; Leker et al., 2007; Jin-qiao et al., 2009) to enhance vascular regeneration and brain synaptic plasticity, while it…”
BackgroundDempsey, R. J., Sailor, K. A., Bowen, K. K., Türeyen, K., & Vemuganti, R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02022.x · Cited by 176 · cited 1×
“…such as epidermal growth factor, glial cell-derived neurotrophic factor, FGF-2, insulin-like growth factor-1, and brain-derived neurotrophic factor (Dempsey et al., 2003; Kobayashi et al., 2006; Leker et al., 2007; Jin-qiao et al., 2009) to enhance vascular regeneration and brain synaptic…”
BackgroundBrain Atrophy and Cerebral Small Vessel Disease: A Prospective Follow-Up Study
Nitkunan, A., Lanfranconi, S., Charlton, R. A., Barrick, T. R., & Markus, H. S. (2011) · Stroke · doi:10.1161/strokeaha.110.594267 · Cited by 135
Vitturi, D. A., & Patel, R. P. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.037 · Cited by 59 · cited 1×
“…excessive formation of reactive radical oxide species (ROS) and/or peroxynitrite (Peters et al., 1998; Bolanos and Almeida, 1999; Shen et al., 2003; Vitturi and Patel, 2011; Kietadisorn et al., 2012; Li et al., 2012; Olmez and Ozyurt, 2012; Rodriguez et al., 2013) and activation of the immune…”
Background
Cited by
Activating Wnt/β-catenin signaling pathway for disease therapy: Challenges and opportunities
Huang, P., Yan, R., Zhang, X., Wang, L., Ke, X., & Qu, Y. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.008 · Cited by 268
Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions
Bhalla, S., Mehan, S., Khan, A., & Rehman, M. U. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104896 · Cited by 108
Serum/glucocorticoid regulated kinase 1 (SGK1) in neurological disorders: pain or gain
Howard, P. G., Zou, P., Zhang, Y., Huang, F., Tesic, V., Wu, C. Y.-C., & Lee, R. H.-C. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114973 · Cited by 13
Self-citation
Metadata
- Authors
- Lin, H., Lee, R. C., Lee, M. H., Wu, C. C., Couto e Silva, A., Possoit, H., Hsieh, T.-H., & Minagar, A.
- Venue
- Neural Regeneration Research
- Publisher
- Medknow
- Published
- 2018
- Volume
- 13
- Issue
- 3
- Pages
- 373
- ISSN
- 1673-5374 (ISSN-L)
- OpenAlex
- W2795560018
- Cited by
- 204
- References
- 27
- FWCI
- 8.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.